Postdoctoral Research Fellow

The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.

The petitioner proposes to continue research into uncovering the genetic mechanisms that cause resistance to cancer therapies. Using state-of-the-art screening techniques, the work aims to accelerate the development of next-generation combination therapies to overcome tumor resistance. The endeavor focuses on exploring gene targets affecting immunotherapy response and examining the molecular behavior of oncogenic proteins.

The petitioner proposes to identify molecular mechanisms underlying chemotherapeutic resistance and develop molecular diagnostics for solid tumors. This work involves investigating patient-derived organoid cultures, CRISPR engineering, and high-throughput drug testing to improve early cancer detection and patient outcomes.

The petitioner proposes to continue his research on developing state-of-the-art approaches for identifying biomarkers and therapeutic targets involved in drug resistance. The work focuses on implementing these findings into routine patient care to improve survival rates for cancer patients, specifically those with thoracic cancers like lung cancer.